Immunocore

Biotech · Public

ImmTAC bispecific T cell engager molecules targeting intracellular cancer antigens

immunocore.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
1 granted · 1 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1920ONCOTHERAPY SOLUTIONS, LLC——
1921WILD MICROBES CO——
1922Onramp Invest, Inc.—$5.0M
1923Immunocore——
1924MOGLING BIO INC——
1925Arch Innotek, LLC——
1926GENELANCET BIOSCIENCES INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 2

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.